FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
Emergent novel SARS-CoV-2 is responsible for the current pandemic outbreak of severe acute respiratory syndrome with high mortality among the symptomatic population worldwide. Given the absence of a current vaccine or specific antiviral treatment, it is urgent to search for FDA-approved drugs that c...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Další autoři: | , , |
| Médium: | Artículo |
| Jazyk: | English |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://doi.org/10.1080/07391102.2020.1764393 https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1764393?needAccess=true |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|
